Evidence check: NutriCare | INFINITY DNA-Test in the context of weight loss

The NutriCare | INFINITY DNA test is marketed for weight loss, but it relies on nutrigenetic variants (e.g., FTO, PPARGC1A, TCF7L2) with small effect sizes on metabolism and satiety. Evidence for clinically meaningful weight loss prediction is weak: GWAS associations show modest risk changes (e.g., OR 1.5 for TCF7L2 in diabetes), but lifestyle (calorie balance, exercise) overwhelmingly determines outcomes. The test may serve as a motivational tool but does not replace medical advice or evidence-based diet. Caveat: results are predispositive, not diagnostic. A blood test for biomarkers (e.g., HbA1c, insulin) would be more informative. Safety note: No direct risks, but misinterpretation may lead to unnecessary dietary restrictions.